4.88
-0.63 (-11.43%)
-0.63 (-11.43%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 9,651,014 |
|
|||||
| News | (1) | ||||||
| Day High | 5.58 | Low High |
|||||
| Day Low | 4.92 | ||||||
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Sorrento Therapeutics Inc | SRNE | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| -0.63 | -11.43% | 4.88 | 19:59:53 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 5.51 | 4.92 | 5.58 | 4.945 | 5.51 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 33,331 | 9,651,014 | $ 5.11 | $ 49,282,699 | - | 4.92 - 17.25 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:22 | 15 | $ 4.88 | USD |
Period:
Draw Mode:
Sorrento Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 1.49B | 306.34M | 301.62M | $ 39.99M | $ - | -1.30 | -4.60 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 3.95M | 34.60% |
Sorrento Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SRNE Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 5.91 | 6.17 | 4.92 | 5.76 | 5,286,490 | -1.03 | -17.43% |
| 1 Month | 6.82 | 6.99 | 4.92 | 6.11 | 5,111,006 | -1.94 | -28.45% |
| 3 Months | 8.05 | 8.275 | 4.92 | 6.78 | 4,771,121 | -3.17 | -39.38% |
| 6 Months | 8.42 | 11.07 | 4.92 | 8.12 | 5,632,124 | -3.54 | -42.04% |
| 1 Year | 7.79 | 17.25 | 4.92 | 9.53 | 9,128,427 | -2.91 | -37.36% |
| 3 Years | 3.52 | 21.26 | 1.39 | 8.09 | 11,558,645 | 1.36 | 38.64% |
| 5 Years | 5.15 | 21.26 | 1.39 | 7.86 | 7,571,631 | -0.27 | -5.24% |
Sorrento Therapeutics Description
| Sorrento Therapeutics Inc is a biotechnology company focused on the development of novel immunotherapies for oncology and autoimmune/inflammation diseases. The antibody technologies target various locations: extracellular, intracellular, and membrane-bound antigens. The product portfolio consists of BioSimilar/BioBetter antibodies, CAR-T programs for treatment of solid tumors, adoptive cellular therapies, immuno-oncology mAbs, and antibody drug conjugates. |
